Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Changchun University Of Chinese Medicine currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by 1 distinct examiner, Michael P Cohen. The case is situated within 1 distinct art unit. Michael P Cohen is the busiest examiner, with 1 busiest examiner pending action. This 1 action represents the total volume of pending office actions for the company.
For a practitioner, the prosecution of this Biotechnology & Pharmaceuticals application is highly focused, requiring a direct engagement with this 1 distinct examiner to resolve the outstanding office action. The involvement of 1 distinct art unit suggests that the technical claims are being evaluated by a specific specialized group within the USPTO. Michael P Cohen is the only official managing the 1 pending office action, so the legal team can focus entirely on his specific feedback. This 1 busiest examiner pending action is the only active matter in the portfolio, allowing for a concentrated effort to overcome any rejections. Practitioners should review the past examination patterns of Michael P Cohen within the Biotechnology & Pharmaceuticals field to better inform their response to the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COHEN, MICHAEL P | 1 | 58.9% | +27.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18884875 | GRAPHENE ACUPOINT HERBAL PATCH (AHP) FOR WARMING UTERUS AND RELIEVING PAIN, METHOD OF PREPARATION AND USE THEREOF | COHEN, MICHAEL P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18884875 | GRAPHENE ACUPOINT HERBAL PATCH (AHP) FOR WARMING UTERUS AND RELIEVING PAIN, METHOD OF PREPARATION AND USE THEREOF | COHEN, MICHAEL P | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18884875 | GRAPHENE ACUPOINT HERBAL PATCH (AHP) FOR WARMING UTERUS AND RELIEVING PAIN, METHOD OF PREPARATION AND USE THEREOF | COHEN, MICHAEL P | 1612 | §103§112 | Non-Final OA | — | Pending | Sep 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChangchun University Of Chinese Medicine has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Michael P Cohen has the most, with 1 of Changchun University Of Chinese Medicine's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
